Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
Blankestijn PJ, Fischer KI, Barth C, Cromm K, Canaud B, Davenport A, Grobbee DE, Hegbrant J, Roes KC, Rose M, Strippoli GF, Vernooij RW, Woodward M, de Wit GA de, Bots ML. Blankestijn PJ, et al. Among authors: hegbrant j. BMJ Open. 2020 Feb 5;10(2):e033228. doi: 10.1136/bmjopen-2019-033228. BMJ Open. 2020. PMID: 32029487 Free PMC article. Clinical Trial.
Correlation of treatment time and ultrafiltration rate with serum albumin and C-reactive protein levels in patients with end-stage kidney disease receiving chronic maintenance hemodialysis: a cross-sectional study.
Zsom L, Zsom M, Fülöp T, Wells C, Flessner MF, Eller J, Wollheim C, Hegbrant J, Strippoli GF. Zsom L, et al. Among authors: hegbrant j. Blood Purif. 2010;30(1):8-15. doi: 10.1159/000314648. Epub 2010 May 20. Blood Purif. 2010. PMID: 20484902
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Strippoli GF; Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE). Strippoli GF, et al. Trials. 2010 Jun 9;11:70. doi: 10.1186/1745-6215-11-70. Trials. 2010. PMID: 20534124 Free PMC article. Clinical Trial.
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies.
Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GF. Navaneethan SD, et al. Among authors: hegbrant j. Am J Kidney Dis. 2010 Oct;56(4):670-85. doi: 10.1053/j.ajkd.2010.06.016. Am J Kidney Dis. 2010. PMID: 20801572 Review.
The quest to standardize hemodialysis care.
Hegbrant J, Gentile G, Strippoli GFM. Hegbrant J, et al. Contrib Nephrol. 2011;171:39-49. doi: 10.1159/000327338. Epub 2011 May 23. Contrib Nephrol. 2011. PMID: 21625088 Review.
Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study.
Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group; Vecchio M, Palmer S, De Berardis G, Craig J, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Lucisano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Hegbrant J, Wollheim C, De Cosmo S, Manfreda VM, Strippoli GF. Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group, et al. Among authors: hegbrant j. Nephrol Dial Transplant. 2012 Jun;27(6):2479-88. doi: 10.1093/ndt/gfr635. Epub 2011 Dec 29. Nephrol Dial Transplant. 2012. PMID: 22207325
Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.
Strippoli GF, Palmer SC, Ruospo M, Natale P, Saglimbene V, Craig JC, Pellegrini F, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, del Castillo D, Hegbrant J, Wollheim C, Gargano L; ORAL-D Investigators. Strippoli GF, et al. Among authors: hegbrant j. BMC Nephrol. 2013 Apr 19;14:90. doi: 10.1186/1471-2369-14-90. BMC Nephrol. 2013. PMID: 23597063 Free PMC article. Clinical Trial.
87 results